易明医药 (002826.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(易明医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度销售毛利率(%) 60.0061.0058.0046.0044.0043.0045.0043.0044.00
 单季度销售净利率(%) 17.00-7.006.003.005.009.005.002.005.00
 单季度净资产收益率ROE(%) 4.00-1.001.001.001.003.001.00-1.00
 单季度总资产净利率ROA(%) 3.00-1.001.001.001.003.001.00-1.00
单季度财务摘要:
 单季度营业总收入(元) 160,425,522.00128,738,264.00161,865,263.00205,004,729.00171,430,742.00264,966,962.00206,056,228.00199,276,308.00186,434,810.00
 单季度营业总成本(元) 155,954,094.00123,225,226.00160,928,861.00200,360,725.00163,151,788.00255,084,211.00195,632,880.00196,337,461.00175,255,785.00
 单季度营业收入(元) 160,425,522.00128,738,264.00161,865,263.00205,004,729.00171,430,742.00264,966,962.00206,056,228.00199,276,308.00186,434,810.00
 单季度营业利润(元) 32,394,319.00-6,629,586.0011,924,752.007,511,588.0010,698,166.0026,612,772.0012,222,658.005,902,024.0010,991,909.00
 单季度利润总额(元) 32,480,811.00-6,252,599.0011,788,270.007,418,508.0010,645,350.0027,794,561.0011,856,403.006,158,854.0010,892,783.00
 单季度净利润(元) 28,050,728.00-8,674,158.009,748,005.006,172,919.008,478,873.0024,634,779.009,291,873.003,549,667.008,639,617.00
 单季度归属母公司股东的净利润(元) 27,899,080.00-8,501,473.009,807,201.005,717,248.008,363,504.0022,889,803.009,271,624.003,445,567.008,528,415.00
 单季度经营活动产生的现金流量(元) 53,738,523.0088,775,223.0042,321.0046,235,062.0031,828,337.00-23,434,388.0050,521,729.0046,556,084.00-5,190,203.00
 单季度投资活动产生的现金流量(元) -154,482,257.0069,037,515.0080,390,714.00-92,210,083.00-100,219,757.0099,680,501.00-49,870,808.00-79,036.00-51,446,057.00
 单季度筹资活动产生的现金流量(元) -24,601,989.00851,139.00-59,196,664.00-495,188.00-462,500.00-504,268.0030,677,543.00--
 单季度现金及现金等价物净增加(元) -125,375,241.00158,266,819.0021,001,722.00-45,758,990.00-68,936,596.0075,644,570.0031,418,912.0043,887,042.00-56,638,556.00

前瞻产业研究院